Open AccessCytomegalovirus Donor Seropositivity Negatively Affects Survival After Heart Transplantation
Author(s) -
Christian Heim,
P Müller,
R. Tandler,
Wida S. Cherikh,
Alice E. Toll,
Josef Stehlik,
Michael Weyand,
Kiran K. Khush,
Stephan Ensminger
Publication year - 2022
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003961
Subject(s) - medicine , transplantation , lung transplantation , cytomegalovirus , serology , heart transplantation , risk factor , creatinine , human cytomegalovirus , confidence interval , retrospective cohort study , gastroenterology , body mass index , cohort , immunology , herpesviridae , viral disease , human immunodeficiency virus (hiv) , antibody , virus
Prior studies have shown that cytomegalovirus (CMV) infection is a risk factor for the development of cardiac allograft vasculopathy (CAV) and is associated with reduced long-term survival after heart transplantation (HTx). The aim of this International Society for Heart and Lung Transplantation Transplant Registry study was to compare posttransplant survival in different CMV donor:recipient serologic combinations.